LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 363 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $249,000 | -79.2% | 3,425 | -61.2% | 0.00% | -75.0% |
| Q4 2018 | $1,198,000 | +385.0% | 8,825 | +880.6% | 0.01% | +700.0% |
| Q3 2018 | $247,000 | -32.7% | 900 | -87.0% | 0.00% | -66.7% |
| Q4 2014 | $367,000 | -34.9% | 6,900 | -42.5% | 0.00% | -40.0% |
| Q3 2014 | $564,000 | -50.6% | 12,000 | -30.2% | 0.01% | -37.5% |
| Q2 2014 | $1,141,000 | -68.9% | 17,200 | -65.2% | 0.01% | -70.4% |
| Q1 2014 | $3,668,000 | – | 49,400 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |